Author: James Love
Prostate cancer patients ask Secretary Beccera to act on their appeal of rejection of the Xtandi march in and government use petititon
On December 19, 2023, three prostate cancer patients, Robert Sachs, Clare Love and Eric Sawyer, sent a letter to Secretary Becerra asking that he act on their appeal of the rejection of their petition, asking the federal government to use… Continue Reading
A quick FAQ on Bayh-Dole Act march-in rights
For journalists writing about march-in rights today, this is how it works. If you get money from the federal government for the R&D leading to an invention, there is typically a contract that gives the funder certain rights in any… Continue Reading
WHO Working Group on Amendments to the International Health Regulations
KEI statement to the Working Group on Amendments to the International Health Regulations December 7, 2023 KEI agrees with others that the IHR regulations should incorporate measures to address equitable access to products. KEI reminds delegations that in 2019, the… Continue Reading
KEI initial comments on Draft text for a WIPO Broadcast Organization treaty, SCCR/44/3, Article 2,3,5,8 and 14
SCCR-44-3-Articles-2-3-5-8-14-comments-24oct2023 This is a comment on the most recent version of the proposed WIPO treaty for broadcasting organizations, SCCR/44/3. KEI’s primary concerns with SCCR/44/3 discussed in this note are that the definitions of broadcasting and protected programmes are too broad,… Continue Reading
Slides of KEI side event on U.S. government use of FAR 52.227-1 for non voluntary use of patented inventions
Today KEI hosted a side event at WIPO on the United States use of FAR 52.227-1. These are the slides I used.Slide 11 provides a link to more than 350 contracts that have his clause for a variety of purposes.… Continue Reading
USITC avoids taking sides in 497 page report on WTO limited patent extension of exceptions for COVID 19
The USITC has issued a 497 page report on the WTO negotiations over TRIPS and COVID. https://www.usitc.gov/publications/332/pub5469.pdf The USITC release states: The U.S. International Trade Commission (USITC) today released a report about COVID-19 diagnostics and therapeutics and certain flexibilities under… Continue Reading
Summary of KEI’s September 28, 2023 comments to the TRIPS Council On Paragraph 8 Of The Ministerial Decision On The TRIPS Agreement
Summary of September 28, 2023 comments to the TRIPS Council On Paragraph 8 Of The Ministerial Decision On The TRIPS Agreement James Love Knowledge Ecology International (KEI) The June 17, 2022 decision on the TRIPS Agreement and COVID-19 vaccines was… Continue Reading
Scarlet TCR: Comments on a NIH prospective exclusive patent license for treatment of HPV cancers
Updates: Senator Sanders Sends Letter to HHS Inspector General Urging Investigation of Exclusive Patent License for NIH-funded Cancer Therapy, Press Release. October 23, 2023. David Dayen, “Sanders Seeks Investigation of NIH Licensing Practices: The senator wants the inspector general to… Continue Reading